Previous studies have identified a down-regulation of adiponectin and its receptors in pathologies characterised by chronic inflammation such as obesity and type-II DM (Kadowaki & Yamauchi, 2005; Tsuchida et al., 2004). Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.